Evidence map›Paper›PMID 41587897›Full record

ArticleACS infectious diseases2026

Recombinant Human IgG1 Enhances Complement-Mediated Bacteriolysis and Macrophage Phagocytosis of

Thae Thae Min, Audrey Guilbaud, Frédéric Pecorari, Pawana Panomket, Nitima Suttipanta, Dietmar Haltrich, Pattra Suntornthiticharoen, Montarop Yamabhai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thae Thae MinMolecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
Audrey GuilbaudNantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes F-44000, France.
Frédéric PecorariNantes Université, Université d'Angers, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes F-44000, France.
Pawana PanomketCollege of Medicine and Public Health, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.
Nitima SuttipantaCollege of Medicine and Public Health, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand.
Dietmar HaltrichDepartment of Biotechnology and Food Science, BOKU University, Vienna 1190, Austria.ORCID 0000-0002-8722-8176
Pattra SuntornthiticharoenDepartment of Medical Science, Faculty of Science, Rangsit University, Pathumthani 12000, Thailand.
Montarop YamabhaiMolecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.ORCID 0000-0003-2674-2419

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of innovative therapeutics against WHO priority pathogens is an urgent global need. Here, we demonstrate the functionalities of a human antibody, previously isolated by whole cell biopanning of the phage display scFv library. The yPgi3G4 IgG1 could mediate antibody-dependent phagocytosis of

Indexed as

BacteriolysisComplement System ProteinsImmunoglobulin GMacrophagesPhagocytosisPseudomonas aeruginosaAnti-Bacterial AgentsHumansLipopolysaccharidesRecombinant ProteinsTHP-1 CellsAnti-Bacterial AgentsComplement System ProteinsImmunoglobulin GLipopolysaccharidesRecombinant Proteinscaveolaecomplement systemlipopolysaccharidesP. aeruginosaphagocytosisrecombinant IgG1

Identifiers

PMID41587897
PMCPMC12910584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.